Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
As an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, retatrutide is not currently approved in the UK and remains available only within authorised clinical trials
The choice of agent depends on individual circumstances, symptom severity, and concurrent medical conditions
The gastrointestinal side effects of GLP-1 agentsparticularly vomiting and diarrheacan lead to depletion of essential electrolytes including sodium, magnesium, potassium, and calcium, all of which are critical for normal muscle contraction and relaxation
The sulfur compounds in eggs make them particularly problematic
US$ 20.67
US$ 28.61
US$ 26.41
US$ 27.69
US$ 24.40
US$ 28.61
